CTCX: Carmell Corporation Company Short-Term Debt

Symbol and logo of brand Carmell Corporation (CTCX)

Carmell Corporation (CTCX) generates revenue from the supply of regenerative materials for plastic surgeons and cosmetology. Its own cGMP-compliant facilities in Pennsylvania ensure production stability. The stock price trend on GURU.Markets is 0.00, while low sales volumes are currently inflating operating expenses, temporarily limiting the business scaling of plasma product commercialization.

CTCX (Carmell Corp.) Company Short-Term Debts history from 02/21/2024 to 03/10/2025

CTCX (Carmell Therapeutics): analytical breakdowns and indicator data

- current quotes and average value forecast:
Price Chart Carmell|CTCX - Fair Value Consensus
- market capitalization information:
Market Value Carmell Corporation|CTCX - Real Price to Acquire Entire Company
- shareholders' equity book value data:
Book Value per Share Carmell|CTCX - Book Capitalization|Market Cap to Net Assets Ratio carmellrx.com|CTCX - Aggregate Asset Value
- debt and liquidity data:
Debt to Equity Carmell Corporation|CTCX - Long-Term Debt to Equity Ratio|Short-Term Debt to Capital Carmell Corporation|CTCX - Company Cumulative Debt|Debt to Book Value Carmell Corporation|CTCX - Amount of Long-Term Liabilities|Company Short-Term Debts Carmell|Quick Ratio carmellrx.com
- net income and valuation multiples indicators:
CTCX - Company Net Income
Basic company analysis:Carmell - CTCX
Mass-produced product of Carmell Therapeutics

To protect capital from market volatility, it is critical for investors to assess a business's ability to service its obligations without creating cash flow gaps. The implementation of waste-free biomaterial synthesis technologies by Carmell Corporation (CTCX) optimizes operating expenses, which directly impacts short-term debt maturing within one year—measuring the total volume of loans due within twelve months to analyze current solvency and the financial stability of the portfolio.

Who Carmell Corporation competes with

ASND - Company Short-Term Debt|Company Short-Term Loans and Borrowings MDGL (Madrigal Pharmaceuticals Inc)|Corcept (CORT) - Company Short-Term Debt|Company Current Liabilities Rhythm Corp|AKRO (Akero Therapeutics) - Company Short-Term Debts|Company Short-Term Debts metsera.com|Company Current Liabilities MLTX (MoonLake)|CRNX (Crinetics Pharmaceuticals, Inc.) - Company Short-Term Loans and Borrowings|Company Short-Term Debt NewAmsterdam Pharma N.V. NAMS|SLNO - Company Current Liabilities|Amicus Therapeutics - Company Short-Term Debts|Short-Term Debt 89bio.com|AGIO (Agios Pharmaceuticals, Inc.) - Company Current Liabilities|GPCR: Amount of Current Liabilities|MDXG (MiMedx Group) - Company Short-Term Debts|Company Short-Term Debts Rezolute Bio|Company Short-Term Debts LXRX|Company Short-Term Debt MBX (mbxbio.com)|Company Short-Term Debt Altimmune ALT|Aardvark Therapeutics Inc. (AARD) - Short-Term Debt|SGMT - Company Short-Term Debt|BIOA: Company Short-Term Debt|BMEA: Company Short-Term Debts|QNCX - Short-Term Debt Volume|Company Short-Term Debt Fractyl Health|vTv Therapeutics Inc (VTVT) - Short-Term Debt Volume|Company Short-Term Debt Agape ATP Corporation (ATPC)|Company Current Liabilities pluri-biotech.com PLUR|Company Short-Term Debts SYBX (Synlogic)|LPCN - Company Current Liabilities|Matinas BioPharma Holdings Inc. - Company Short-Term Debts|SPRB - Company Short-Term Debts|Galecto Corp (GLTO) - Company Short-Term Debt|Lumos Therapeutics - Company Short-Term Loans and Borrowings|Company Short-Term Debt Organovo Holdings, Inc.|Company Current Liabilities radiuspharm.com (RDUS)